Skip to main content
Top
Published in: Arthritis Research & Therapy 3/2006

Open Access 01-06-2006 | Research article

Osteogenic protein 1 in synovial fluid from patients with rheumatoid arthritis or osteoarthritis: relationship with disease and levels of hyaluronan and antigenic keratan sulfate

Authors: Susan Chubinskaya, Benjamin S Frank, Margaret Michalska, Bhavna Kumar, Charis A Merrihew, Eugene J-MA Thonar, Mary Ellen Lenz, Lori Otten, David C Rueger, Joel A Block

Published in: Arthritis Research & Therapy | Issue 3/2006

Login to get access

Abstract

The measurement of body fluid levels of biochemical markers in joint tissues has begun to provide clinically useful information. Synovial fluid (SF) plays an important role in articular joint lubrication, nutrition, and metabolism of cartilage and other connective tissues within the joint. The purpose of our study was to identify and characterize osteogenic protein 1 (OP-1) in SF from patients with rheumatoid arthritis (RA) or with osteoarthritis (OA) and to correlate levels of OP-1 with those of hyaluronan (HA) and antigenic keratan sulfate (AgKS). SF was aspirated from the knees of patients with either RA or OA and from the knees of asymptomatic organ donors with no documented history of joint disease. The presence of detectable OP-1 in SF was demonstrated by western blots with specific anti-pro-OP-1 and anti-mature OP-1 antibodies. Measurement of levels of OP-1, HA and AgKS was performed using ELISAs. OP-1 was identified in human SF in two forms, pro-OP-1 and active (mature) OP-1 – mature OP-1 being detected only in SF from OA patients and RA patients. Levels of OP-1 and HA were higher in RA patients than in OA patients and asymptomatic donors, while the level of AgKS was highest in SF from asymptomatic donors. Statistically significant differences were found between SF levels of OP-1 in RA and OA patients and between SF levels of AgKS among the three groups tested. The SF content of OP-1 tended to correlate positively with HA levels, but negatively with AgKS concentrations. In conclusion, the results of this study suggest that measurement of OP-1 in joint fluid may have value in the clinical evaluation of joint disease processes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Thonar EJ-MA, Manicourt D-H: Noninvasive markers in osteoarthritis. Osteoarthritis: Diagnosis and Medical/Surgical Management. Edited by: Moskowitz R, Goldberg V, Howell DS, Altman RD, Buckwalter J. 2001, Philadelphia, PA: WB Saunders, 293-313. 3 Thonar EJ-MA, Manicourt D-H: Noninvasive markers in osteoarthritis. Osteoarthritis: Diagnosis and Medical/Surgical Management. Edited by: Moskowitz R, Goldberg V, Howell DS, Altman RD, Buckwalter J. 2001, Philadelphia, PA: WB Saunders, 293-313. 3
2.
go back to reference Thonar EJ-MA, Kuettner KE, Williams JM: Markers of articular cartilage injury and healing. Sports Medicine and Arthroscopy Review. 1994, New York: Raven Press, 13-28. Thonar EJ-MA, Kuettner KE, Williams JM: Markers of articular cartilage injury and healing. Sports Medicine and Arthroscopy Review. 1994, New York: Raven Press, 13-28.
3.
go back to reference Campion GV, McCrae F, Schnitzer TJ, Lenz ME, Dieppe PA, Thonar EJ-MA: Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum. 1991, 34: 1254-1259.CrossRefPubMed Campion GV, McCrae F, Schnitzer TJ, Lenz ME, Dieppe PA, Thonar EJ-MA: Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum. 1991, 34: 1254-1259.CrossRefPubMed
4.
go back to reference Manicourt D-H, Triki R, Fukuda K, Devogelaer J-P, Nagant de Deuxchaisnes C, Thonar EJ-MA: Levels of circulating tumor necrosis factor α and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratin sulfate. Arthritis Rheum. 1993, 36: 490-499.CrossRefPubMed Manicourt D-H, Triki R, Fukuda K, Devogelaer J-P, Nagant de Deuxchaisnes C, Thonar EJ-MA: Levels of circulating tumor necrosis factor α and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratin sulfate. Arthritis Rheum. 1993, 36: 490-499.CrossRefPubMed
5.
go back to reference Manicourt D-H, Poilvache P, van Egeren A, Devogelaer J-P, Lenz ME, Thonar EJ-MA: Synovial fluid levels of tumor necrosis factor α and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum. 2000, 43: 281-288. 10.1002/1529-0131(200002)43:2<281::AID-ANR7>3.0.CO;2-7.CrossRefPubMed Manicourt D-H, Poilvache P, van Egeren A, Devogelaer J-P, Lenz ME, Thonar EJ-MA: Synovial fluid levels of tumor necrosis factor α and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum. 2000, 43: 281-288. 10.1002/1529-0131(200002)43:2<281::AID-ANR7>3.0.CO;2-7.CrossRefPubMed
6.
go back to reference Poole AR: Can serum biomarkers assays measure the progression of cartilage degeneration in osteoarthritis?. Arthritis Rheum. 2002, 46: 2549-2552. 10.1002/art.10586.CrossRefPubMed Poole AR: Can serum biomarkers assays measure the progression of cartilage degeneration in osteoarthritis?. Arthritis Rheum. 2002, 46: 2549-2552. 10.1002/art.10586.CrossRefPubMed
7.
go back to reference Masuhara K, Nakai T, Yamaguchi K, Yamasaki S, Sasaguri Y: Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip. Arthritis Rheum. 2002, 46: 2625-2631. 10.1002/art.10547.CrossRefPubMed Masuhara K, Nakai T, Yamaguchi K, Yamasaki S, Sasaguri Y: Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip. Arthritis Rheum. 2002, 46: 2625-2631. 10.1002/art.10547.CrossRefPubMed
8.
go back to reference Chubinskaya S, Merrihew C, Cs-Szabo G, Mollenhauer J, McCartney J, Rueger DC, Kuettner KE: Human articular chondrocytes express osteogenic protein-1. J Histochem Cytochem. 2000, 48: 239-250.CrossRefPubMed Chubinskaya S, Merrihew C, Cs-Szabo G, Mollenhauer J, McCartney J, Rueger DC, Kuettner KE: Human articular chondrocytes express osteogenic protein-1. J Histochem Cytochem. 2000, 48: 239-250.CrossRefPubMed
9.
go back to reference Söder S, Hakimiyan A, Rueger DC, Kuettner KE, Aigner T, Chubinskaya S: Antisense inhibition of osteogenic protein-1 disturbs human articular cartilage integrity. Arthritis Rheum. 2005, 52: 468-478. 10.1002/art.20856.CrossRefPubMed Söder S, Hakimiyan A, Rueger DC, Kuettner KE, Aigner T, Chubinskaya S: Antisense inhibition of osteogenic protein-1 disturbs human articular cartilage integrity. Arthritis Rheum. 2005, 52: 468-478. 10.1002/art.20856.CrossRefPubMed
10.
go back to reference Flechtenmacher J, Huch K, Thonar EJ-MA, Mollenhauer JA, Davies SR, Schmid TM, Puhl W, Sampath TK, Aydelotte MB, Kuettner KE: Recombinant human osteogenic protein-1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum. 1996, 39: 1896-1904.CrossRefPubMed Flechtenmacher J, Huch K, Thonar EJ-MA, Mollenhauer JA, Davies SR, Schmid TM, Puhl W, Sampath TK, Aydelotte MB, Kuettner KE: Recombinant human osteogenic protein-1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum. 1996, 39: 1896-1904.CrossRefPubMed
11.
go back to reference Chubinskaya S, Rueger DC, Berger RA, Kuettner KE: Osteogenic protein-1 and its receptors in human articular cartilage. The Many Faces of Osteoarthritis. Edited by: Hascall V, Kuettner KE. 2002, Basel: Birkhäuser Verlag, 81-89.CrossRef Chubinskaya S, Rueger DC, Berger RA, Kuettner KE: Osteogenic protein-1 and its receptors in human articular cartilage. The Many Faces of Osteoarthritis. Edited by: Hascall V, Kuettner KE. 2002, Basel: Birkhäuser Verlag, 81-89.CrossRef
12.
go back to reference Chubinskaya S, Kuettner KE: Regulation of osteogenic proteins by chondrocytes. Int J Biochem Cell Biol. 2003, 35: 1323-1340. 10.1016/S1357-2725(03)00035-9.CrossRefPubMed Chubinskaya S, Kuettner KE: Regulation of osteogenic proteins by chondrocytes. Int J Biochem Cell Biol. 2003, 35: 1323-1340. 10.1016/S1357-2725(03)00035-9.CrossRefPubMed
13.
go back to reference Nishida Y, Knudson CB, Kuettner KE, Knudson W: Osteogenic protein-1 promotes the synthesis and retention of extracellular matrix within bovine articular cartilage and chondrocyte cultures. Osteoarthritis Cartilage. 2000, 8: 127-136. 10.1053/joca.1999.0281.CrossRefPubMed Nishida Y, Knudson CB, Kuettner KE, Knudson W: Osteogenic protein-1 promotes the synthesis and retention of extracellular matrix within bovine articular cartilage and chondrocyte cultures. Osteoarthritis Cartilage. 2000, 8: 127-136. 10.1053/joca.1999.0281.CrossRefPubMed
14.
go back to reference Huch K, Wilbrink B, Flechtenmacher J, Koepp HE, Aydelotte MB, Sampath TK, Kuettner KE, Mollenhauer JA, Thonar EJ-MA: Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1β. Arthritis Rheum. 1997, 40: 2157-2161.CrossRefPubMed Huch K, Wilbrink B, Flechtenmacher J, Koepp HE, Aydelotte MB, Sampath TK, Kuettner KE, Mollenhauer JA, Thonar EJ-MA: Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1β. Arthritis Rheum. 1997, 40: 2157-2161.CrossRefPubMed
15.
go back to reference Koepp HE, Sampath KT, Kuettner KE, Homandberg GA: Osteogenic protein-1 (OP-1) blocks cartilage damage caused by fibronectin fragments and promotes repair by enhancing proteoglycan synthesis. Inflamm Res. 1999, 48: 199-204. 10.1007/s000110050446.CrossRefPubMed Koepp HE, Sampath KT, Kuettner KE, Homandberg GA: Osteogenic protein-1 (OP-1) blocks cartilage damage caused by fibronectin fragments and promotes repair by enhancing proteoglycan synthesis. Inflamm Res. 1999, 48: 199-204. 10.1007/s000110050446.CrossRefPubMed
16.
go back to reference Im HJ, Pacione C, Chubinskaya S, Van Wijnen AJ, Sun Y, Loeser RF: Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem. 2003, 278: 25386-25394. 10.1074/jbc.M302048200.PubMedCentralCrossRefPubMed Im HJ, Pacione C, Chubinskaya S, Van Wijnen AJ, Sun Y, Loeser RF: Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem. 2003, 278: 25386-25394. 10.1074/jbc.M302048200.PubMedCentralCrossRefPubMed
17.
go back to reference Rueger DC, Chubinskaya S: BMPs in articular cartilage repair. Bone Morphogenetic Proteins: Regeneration of Bone and Beyond. Edited by: Vukicevic S, Sampath KT. 2004, Basel: Birkhauser Verlag AG, 109-132.CrossRef Rueger DC, Chubinskaya S: BMPs in articular cartilage repair. Bone Morphogenetic Proteins: Regeneration of Bone and Beyond. Edited by: Vukicevic S, Sampath KT. 2004, Basel: Birkhauser Verlag AG, 109-132.CrossRef
18.
go back to reference Merrihew C, Kumar B, Heretis K, Rueger DC, Kuettner KE, Chubinskaya S: Alterations in endogenous osteogenic protein-1 (OP-1) with degeneration of human articular cartilage. J Orthop Res. 2003, 21: 899-907. 10.1016/S0736-0266(03)00055-X.CrossRefPubMed Merrihew C, Kumar B, Heretis K, Rueger DC, Kuettner KE, Chubinskaya S: Alterations in endogenous osteogenic protein-1 (OP-1) with degeneration of human articular cartilage. J Orthop Res. 2003, 21: 899-907. 10.1016/S0736-0266(03)00055-X.CrossRefPubMed
19.
go back to reference Chubinskaya S, Kumar B, Merrihew C, Heretis K, Rueger D, Kuettner KE: Age-related changes in cartilage endogenous OP-1. Biochim Biophys Acta. 2002, 1588: 126-134. 10.1016/S0925-4439(02)00158-8.CrossRefPubMed Chubinskaya S, Kumar B, Merrihew C, Heretis K, Rueger D, Kuettner KE: Age-related changes in cartilage endogenous OP-1. Biochim Biophys Acta. 2002, 1588: 126-134. 10.1016/S0925-4439(02)00158-8.CrossRefPubMed
20.
go back to reference Thonar EJ-MA, Lenz ME, Klintworth GK, Caterson B, Pachman LM, Glickman P, Katz R, Huff J, Kuettner KE: Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum. 1985, 28: 1367-1376.CrossRefPubMed Thonar EJ-MA, Lenz ME, Klintworth GK, Caterson B, Pachman LM, Glickman P, Katz R, Huff J, Kuettner KE: Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum. 1985, 28: 1367-1376.CrossRefPubMed
21.
go back to reference Li X-Q, Thonar EJ-MA, Knudson W: Accumulation of hyaluronate in human lung carcinoma as measured by a new hyaluronate ELISA. Connect Tissue Res. 1989, 19: 243-253.CrossRefPubMed Li X-Q, Thonar EJ-MA, Knudson W: Accumulation of hyaluronate in human lung carcinoma as measured by a new hyaluronate ELISA. Connect Tissue Res. 1989, 19: 243-253.CrossRefPubMed
22.
go back to reference Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al: Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee. Arthritis Rheum. 1986, 29: 1039-1049.CrossRefPubMed Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al: Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee. Arthritis Rheum. 1986, 29: 1039-1049.CrossRefPubMed
23.
go back to reference Merrihew C, Soeder S, Rueger DC, Kuettner KE, Chubinskaya S: Modulation of endogenous osteogenic protein-1 by interleukin-1β in human articular cartilage. J Bone Joint Surg Am. 2003, 85-A (Suppl 3): 67-74.PubMed Merrihew C, Soeder S, Rueger DC, Kuettner KE, Chubinskaya S: Modulation of endogenous osteogenic protein-1 by interleukin-1β in human articular cartilage. J Bone Joint Surg Am. 2003, 85-A (Suppl 3): 67-74.PubMed
24.
go back to reference Lindquist U, Chichibu K, Delpech B, Goldberg RL, Knudson W, Poole AR, Laurent TC: Seven different assays of hyaluronan compared for clinical utility. Clin Chem. 1992, 38: 127-132. Lindquist U, Chichibu K, Delpech B, Goldberg RL, Knudson W, Poole AR, Laurent TC: Seven different assays of hyaluronan compared for clinical utility. Clin Chem. 1992, 38: 127-132.
25.
go back to reference Collins DH: Osteoarthritis. The Pathology of Articular and Spinal Diseases. 1949, Edward Arnold: London, 74-115. Collins DH: Osteoarthritis. The Pathology of Articular and Spinal Diseases. 1949, Edward Arnold: London, 74-115.
26.
go back to reference Jones WK, Richmond EA, White K, Sasak H, Kusmik W, Smart J, Oppermann H, Rueger DC, Tucker RF: Osteogenic protein-1 (OP-1) expression and processing in Chinese hamster ovary cells: isolation of a soluble complex containing the mature and pro-domains of OP-1. Growth Factors. 1994, 11: 215-225.CrossRefPubMed Jones WK, Richmond EA, White K, Sasak H, Kusmik W, Smart J, Oppermann H, Rueger DC, Tucker RF: Osteogenic protein-1 (OP-1) expression and processing in Chinese hamster ovary cells: isolation of a soluble complex containing the mature and pro-domains of OP-1. Growth Factors. 1994, 11: 215-225.CrossRefPubMed
27.
go back to reference Muehleman C, Bareither D, Huch K, Cole A, Kuettner KE: Prevalence of degenerative morphological changes in the joints of the lower extremity. Osteoarthritis Cartilage. 1997, 5: 23-37. 10.1016/S1063-4584(97)80029-5.CrossRefPubMed Muehleman C, Bareither D, Huch K, Cole A, Kuettner KE: Prevalence of degenerative morphological changes in the joints of the lower extremity. Osteoarthritis Cartilage. 1997, 5: 23-37. 10.1016/S1063-4584(97)80029-5.CrossRefPubMed
28.
go back to reference Chubinskaya S, Kuettner KE, Cole AA: Expression of matrix metalloproteinases in human normal and damaged articular cartilage from knee and ankle joints. Lab Invest. 1999, 79: 1669-1677.PubMed Chubinskaya S, Kuettner KE, Cole AA: Expression of matrix metalloproteinases in human normal and damaged articular cartilage from knee and ankle joints. Lab Invest. 1999, 79: 1669-1677.PubMed
29.
go back to reference Taketazu F, Kato M, Gobl A, Iichijo H, ten Dijke P, Itoh J, Kyogoku M, Ronnelid J, Miyazono K, Heldin CH: Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab Invest. 1994, 70: 620-630.PubMed Taketazu F, Kato M, Gobl A, Iichijo H, ten Dijke P, Itoh J, Kyogoku M, Ronnelid J, Miyazono K, Heldin CH: Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab Invest. 1994, 70: 620-630.PubMed
30.
go back to reference Miossec R, Naviliat M, Dupuy DA, Sany J, Banchereau J: Low levels of interleukin-4 and high levelsof transforming growth factor beta in rheumatoid synovitis. Arthritis Rheum. 1990, 33: 1180-1187.CrossRefPubMed Miossec R, Naviliat M, Dupuy DA, Sany J, Banchereau J: Low levels of interleukin-4 and high levelsof transforming growth factor beta in rheumatoid synovitis. Arthritis Rheum. 1990, 33: 1180-1187.CrossRefPubMed
31.
go back to reference Muehleman C, Kuettner KE, Rueger DC, ten Dijke P, Chubinskaya S: Immunohistochemical localization of osteogenic protein-1 and its receptors in rabbit articular cartilage. J Histochem Cytochem. 2002, 50: 1341-1350.CrossRefPubMed Muehleman C, Kuettner KE, Rueger DC, ten Dijke P, Chubinskaya S: Immunohistochemical localization of osteogenic protein-1 and its receptors in rabbit articular cartilage. J Histochem Cytochem. 2002, 50: 1341-1350.CrossRefPubMed
32.
go back to reference Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell L: Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am. 2003, 85-A (Suppl 3): 59-66.PubMed Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell L: Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am. 2003, 85-A (Suppl 3): 59-66.PubMed
33.
go back to reference Elshaier AM, Hakimiyan A, Margulis A, Rueger DC, Chubinskaya S: Effect of IL-1β on OP-1 signaling in human adult articular chondrocytes [abstract]. Trans 51st ORS. 2005, 30: 4- Elshaier AM, Hakimiyan A, Margulis A, Rueger DC, Chubinskaya S: Effect of IL-1β on OP-1 signaling in human adult articular chondrocytes [abstract]. Trans 51st ORS. 2005, 30: 4-
34.
go back to reference Chu CQ, Field M, Allard S, Abney E, Feldman M, Maini RN: Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implication for the role of cytokines in cartilage destruction and repair. Br J Rheumatol. 1992, 31: 653-661.CrossRefPubMed Chu CQ, Field M, Allard S, Abney E, Feldman M, Maini RN: Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implication for the role of cytokines in cartilage destruction and repair. Br J Rheumatol. 1992, 31: 653-661.CrossRefPubMed
35.
go back to reference Fava R, Olsen N, Keski Oja J, Moses H, Pincus T: Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med. 1989, 169: 291-296. 10.1084/jem.169.1.291.CrossRefPubMed Fava R, Olsen N, Keski Oja J, Moses H, Pincus T: Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med. 1989, 169: 291-296. 10.1084/jem.169.1.291.CrossRefPubMed
36.
go back to reference Thonar EJ-MA, Lenz ME, Masuda K, Manicourt D-H: Body fluid markers of cartilage metabolism. Dynamics of Bone and Cartilage Metabolism. Edited by: Seibel MJ, Robins SP, Bilezikian JP. 1999, San Diego, CA: Academic Press, 453-464. Thonar EJ-MA, Lenz ME, Masuda K, Manicourt D-H: Body fluid markers of cartilage metabolism. Dynamics of Bone and Cartilage Metabolism. Edited by: Seibel MJ, Robins SP, Bilezikian JP. 1999, San Diego, CA: Academic Press, 453-464.
37.
go back to reference Sharif M, George E, Shepstone L, Knudson W, Thonar EJ-MA, Cushnaghan J, Dieppe P: Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum. 1995, 38: 760-767.CrossRefPubMed Sharif M, George E, Shepstone L, Knudson W, Thonar EJ-MA, Cushnaghan J, Dieppe P: Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum. 1995, 38: 760-767.CrossRefPubMed
38.
go back to reference Goldberg RL, Huff JP, Lenz ME, Glickman P, Katz R, Thonar EJ-MA: Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1991, 34: 799-807.CrossRefPubMed Goldberg RL, Huff JP, Lenz ME, Glickman P, Katz R, Thonar EJ-MA: Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1991, 34: 799-807.CrossRefPubMed
39.
go back to reference Hedin P-J, Weitoft T, Hedin H, Engstrom-Laurent A, Saxne T: Serum concentrations of hyaluronan and proteoglycan in joint disease: lack of association. J Rheumatol. 1991, 18: 1601-1605.PubMed Hedin P-J, Weitoft T, Hedin H, Engstrom-Laurent A, Saxne T: Serum concentrations of hyaluronan and proteoglycan in joint disease: lack of association. J Rheumatol. 1991, 18: 1601-1605.PubMed
40.
go back to reference Lee S-S, Joo Y-S, Kim W-U, Min D-J, Min J-K, Park S-H, Cho C-S, Kim H-Y: Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2001, 19: 321-324.PubMed Lee S-S, Joo Y-S, Kim W-U, Min D-J, Min J-K, Park S-H, Cho C-S, Kim H-Y: Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2001, 19: 321-324.PubMed
Metadata
Title
Osteogenic protein 1 in synovial fluid from patients with rheumatoid arthritis or osteoarthritis: relationship with disease and levels of hyaluronan and antigenic keratan sulfate
Authors
Susan Chubinskaya
Benjamin S Frank
Margaret Michalska
Bhavna Kumar
Charis A Merrihew
Eugene J-MA Thonar
Mary Ellen Lenz
Lori Otten
David C Rueger
Joel A Block
Publication date
01-06-2006
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 3/2006
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1947

Other articles of this Issue 3/2006

Arthritis Research & Therapy 3/2006 Go to the issue